DMMR CANCER
Clinical trials for DMMR CANCER explained in plain language.
Never miss a new study
Get alerted when new DMMR CANCER trials appear
Sign up with your email to follow new studies for DMMR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy combo may spare cancer patients from surgery
Disease control Recruiting nowThis study tests a combination of immunotherapy drugs (sintilimab, IBI310, lenvatinib) in people with non-spreading stomach or colon cancers that have a specific genetic feature (MSI-H/dMMR). The goal is to see if these drugs can make the cancer disappear or shrink enough so that…
Matched conditions: DMMR CANCER
Phase: PHASE2 • Sponsor: Peking University • Aim: Disease control
Last updated May 26, 2026 12:09 UTC
-
New drug MOMA-341 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new oral drug, MOMA-341, alone or with other treatments, in people with advanced solid tumors that have specific genetic markers (MSI-H or dMMR). The main goal is to check safety and find the best dose. About 132 adults whose cancer has not responde…
Matched conditions: DMMR CANCER
Phase: PHASE1 • Sponsor: MOMA Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:51 UTC